'Pretty alarmed': Thousands of Kiwis with ADHD forced to switch drugs after supply problems
Global demand has been blamed for the shortage of Teva, a common ADHD drug.
AdvertisementAdvertise with NZME.
Latest fromPharmaceuticals
Can some antidepressants cause lasting sexual problems?
NY Times: Some patients say symptoms persist long after they've stopped taking SSRIs.
Obesity drug cuts risk of death by 18 per cent
Wegovy has been found to have a 'quite profound' effect on reducing heart attack risk.
Pseudoephedrine question reflects failure of meth policy - expert
"We have taken the eye off methamphetamine."
‘Meno-washing’: Are midlife women being scammed?
Telegraph: Menopause has come out of the shadows. So have the snake oil merchants.
Some psychiatrists have started prescribing Ozempic. Others are worried
New York Times: 'These medications were not studied well or designed for this population.'
Medicinal cannabis producers gear up to sell products prescription-free
Rule change a 'surprise' but health regulator claims potential safety issues exist.
What is behind the unexpected decline in dementia?
Financial Times: Global data on new cases of dementia offers an unexpected ray of hope.
Pharmac CEO's fate revealed over Rachel Smalley email saga
Pharmac's board met today amid a deepening crisis over internal emails.
Pharmac email crisis: Emailer apologises to Smalley; Chair meets bosses; Calls for CEO sacking
The PM steps into the Pharmac email row, labelling comments 'totally unacceptable'.
Western companies take slow steps towards China ‘de-risking’
Financial Times: Strategies focus on ways to insulate China operations, not reduce them.
Young mum's $100k bill for cancer drugs that has political parties at odds
Adrienne Smithson says her 'world was tipped upside down' after her diagnosis at age 44.
Opinion: The economic promise of anti-obesity drugs
Financial Times: Over 1 billion people worldwide are obese, according to the WHO.
How Ozempic and Wegovy are reshaping Denmark's economy
New York Times: Novo Nordisk’s market value has exceeded the size of the Danish economy.
Superbugs: Why it’s so hard to stop the ‘silent pandemic’
Financial Times: Antimicrobial resistance already kills millions - and it's getting worse.
'We are in a crisis': Patients call for access to new meds
MyLifeMatters collective represents over a million patients with life-limiting conditions.
Opinion | Pharmac in the dark shadow of adversarial politics
OPINION: Drug-buying agency has received huge criticism. For what?
Andrew Young: Time to mobilise to fight cancer
OPINION: Why your support for the Cancer Society's Daffodil Day matters.
A shot in the dark: Nobody knows why new weight-loss drugs work
NY Times: Drug makers 'got lucky', experts say - and there's still a lot they don't know.
Ozempic, saunas and cottage cheese: 5 wellness trends to watch
New York Times: A look at the pills, products and practices that have popped up in 2023.
'Deliberate and unethical': Pharmacist stole methadone, topped up bottles with water
John Collett moved the methadone to a small bottle, then put it in his pocket.
Opinion: A single Ozempic injection almost hospitalised me
Telegraph: 'I never expected a licensed drug to make me feel so bad.'
First pill to treat postnatal depression approved in US
Postpartum depression can continue for months or even years.
Free medicine deliveries will help address healthcare inequity for Māori and Pasifika - pharmacist
For many, just driving to the pharmacy is a significant barrier.
Sickness, misery and shedding kilos: My first two months on Ozempic
Telegraph: Yes, semaglutide works. But there's a price to pay, says a UK patient.
The risks of taking drugs like Ozempic when you’re over 65
New York Times: The weight-loss equation changes for older adults, experts say.
‘The smell of human breath made me vomit’: Could this be the end of morning sickness?
Telegraph: A new study points the finger at a little-known hormone called GDF15.
Pharmacies v Chemist Warehouse - who’s winning the medicine mark up?
Life Pharmacy and Unichem are having to lower their prices.
'Ban it': NZ medical experts call out pharmaceutical advertising
The Council of Medical Colleges want to stop the advertisement of medicines.
Enforcers and budding entrepreneurs: The medicinal cannabis power list
The dope dozen: the most influential NZ players on the medicinal scene.
The silent change: What to expect when going through perimenopause
BIG READ: Dr Linda Dear labels perimenopause a "blind spot".
'Tour de force' in heritage restoration wins Property Council award
Sensitive refurbishment and amalgamation of the buildings takes prize.
How a generation of men got hooked on anti-hair loss drugs
Telegraph: Jack Rear started taking finasteride even though he wasn't sure he needed it.
Is a revolution in cancer treatment within reach?
New York Times: Once-deadly diseases are now survivable, writes Kate Pickert.